Operating Lease, Right-of-Use Asset of Voyager Therapeutics, Inc. from 31 Mar 2019 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Voyager Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2019 to 31 Dec 2025.
  • Voyager Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2025 was $28,478,000, a 15% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Voyager Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $28,478,000 -$4,871,000 -15% 31 Dec 2025 10-K 09 Mar 2026 2025 FY
Q3 2025 $29,740,000 -$4,783,000 -14% 30 Sep 2025 10-Q 10 Nov 2025 2025 Q3
Q2 2025 $30,973,000 -$4,541,000 -13% 30 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 $32,128,000 -$7,076,000 -18% 31 Mar 2025 10-Q 06 May 2025 2025 Q1
Q4 2024 $33,349,000 +$19,839,000 +147% 31 Dec 2024 10-K 09 Mar 2026 2025 FY
Q3 2024 $34,523,000 +$20,497,000 +146% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 $35,514,000 +$20,986,000 +144% 30 Jun 2024 10-Q 06 Aug 2024 2024 Q2
Q1 2024 $39,204,000 +$24,188,000 +161% 31 Mar 2024 10-Q 13 May 2024 2024 Q1
Q4 2023 $13,510,000 -$1,975,000 -13% 31 Dec 2023 10-K 11 Mar 2025 2024 FY
Q3 2023 $14,026,000 -$1,915,000 -12% 30 Sep 2023 10-Q 06 Nov 2023 2023 Q3
Q2 2023 $14,528,000 -$1,863,000 -11% 30 Jun 2023 10-Q 03 Aug 2023 2023 Q2
Q1 2023 $15,016,000 -$17,362,000 -54% 31 Mar 2023 10-Q 09 May 2023 2023 Q1
Q4 2022 $15,485,000 -$17,973,000 -54% 31 Dec 2022 10-K 28 Feb 2024 2023 FY
Q3 2022 $15,941,000 -$17,858,000 -53% 30 Sep 2022 10-Q 08 Nov 2022 2022 Q3
Q2 2022 $16,391,000 -$17,751,000 -52% 30 Jun 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 $32,378,000 -$2,735,000 -7.8% 31 Mar 2022 10-Q 04 May 2022 2022 Q1
Q4 2021 $33,458,000 -$2,606,000 -7.2% 31 Dec 2021 10-K 07 Mar 2023 2022 FY
Q3 2021 $33,799,000 +$7,668,000 +29% 30 Sep 2021 10-Q 02 Nov 2021 2021 Q3
Q2 2021 $34,142,000 +$7,154,000 +27% 30 Jun 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 $35,113,000 +$7,375,000 +27% 31 Mar 2021 10-Q 10 May 2021 2021 Q1
Q4 2020 $36,064,000 +$7,592,000 +27% 31 Dec 2020 10-K 08 Mar 2022 2021 FY
Q3 2020 $26,131,000 -$3,200,000 -11% 30 Sep 2020 10-Q 09 Nov 2020 2020 Q3
Q2 2020 $26,988,000 -$3,053,000 -10% 30 Jun 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 $27,738,000 -$2,556,000 -8.4% 31 Mar 2020 10-Q 06 May 2020 2020 Q1
Q4 2019 $28,472,000 31 Dec 2019 10-K 25 Feb 2021 2020 FY
Q3 2019 $29,331,000 30 Sep 2019 10-Q 06 Nov 2019 2019 Q3
Q2 2019 $30,041,000 30 Jun 2019 10-Q 09 Aug 2019 2019 Q2
Q1 2019 $30,294,000 31 Mar 2019 10-Q 07 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.